J&J Skin Care Boosted By Aveeno, Sun Care In Q3
This article was originally published in The Rose Sheet
Executive Summary
Johnson & Johnson's worldwide skin care business achieved sales growth of 7.9% to $421 mil. in the third quarter, boosted in part by the strength of Aveeno in the U.S. market, VP-Investor Relations Helen Short reported Oct. 15